Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 2/20 | 0.35 |
| ▸ | XDH | P47989 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.33 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19909300 | 0.96 | STS (0.38) | STSCYP11B1CYP11B2CYP19A1FLT3 | |
| SCHEMBL19909006 | 0.95 | STS (0.38) | STSCYP11B1CYP11B2CYP19A1PTGER4 | |
| SCHEMBL20923142 | 0.94 | CYP19A1 (0.38) | STSCYP11B1CYP11B2CYP19A1PTGER4 | |
| SCHEMBL19909297 | 0.94 | STS (0.38) | STSCYP11B1CYP11B2CYP19A1FLT3 | |
| SCHEMBL19909084 | 0.92 | CYP19A1 (0.38) | CYP11B1CYP11B2CYP19A1PTGER4FLT3 | |
| SCHEMBL20923144 | 0.91 | CYP19A1 (0.40) | STSCYP11B1CYP11B2CYP19A1FLT3 | |
| SCHEMBL20923277 | 0.91 | CYP19A1 (0.40) | STSCYP11B1CYP11B2CYP19A1FLT3 | |
| SCHEMBL19919784 | 0.91 | PTGER4 (0.38) | CYP11B1CYP11B2CYP19A1PTGER4FLT3 | |
| SCHEMBL19919612 | 0.89 | TRPA1 (0.41) | CYP11B1CYP11B2CYP19A1 | |
| SCHEMBL22170341 | 0.89 | FLT3 (0.40) | STSCYP11B1CYP11B2CYP19A1FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | CYNORA GMBH (DE) | 2020-05-26 | — | — | US | disclosed |
| US-20180062085-A1 | ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10665792-B2 | Organic molecules for use in optoelectronic devices | OR10J3, CFD, AOX1 | STS 2306/4885CYP11B1 1400/4885CYP11B2 965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.